FDA
approval
· 2022-12-16
FDA Approved: CYTALUX — Supplemental Application (On Target Laboratories, Inc.)
Summary
FDA approved a supplemental application for CYTALUX (pafolacianine injection) by On Target Laboratories, expanding the product's labeling. The expansion relates…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for CYTALUX (PAFOLACIANINE INJECTION)